Atlas Trials

Extended-Release Buprenorphine vs. Sublingual Buprenorphine for the Treatment of Opioid Use Disorder

Clinical trial NCT04352166 · SUSPENDED

Trial details

NCT number
NCT04352166
Sponsor
Frances R Levin
Status
SUSPENDED
Phase
Phase 2
Study type
INTERVENTIONAL
Opioid-use Disorder
Start date
2020-12-15
Primary completion
2025-06-30
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.